Dydrogesterone (duphaston) and its 20-dihydro- metabolite as selective modulators of estrogenic enzymes in human breast cancer cells
- 作者: Thole Н.1, Chetrite G.2, Philippe G.2, Pasqualini J.2
-
隶属关系:
- Solvay Pharmaceuticals GmbH
- Institut de Puericulture
- 期: 卷 54, 编号 2 (2005)
- 页面: 67-72
- 栏目: Original Research
- URL: https://journals.rcsi.science/jowd/article/view/82486
- DOI: https://doi.org/10.17816/JOWD82486
- ID: 82486
如何引用文章
全文:
详细
The presented data open up interesting prospects for studying the biological responses of progestogens in clinical trials in patients with breast cancer. Estradiol is one of the main factors that control the growth and development of breast cancer. Therefore, an important goal of research in recent years is to block the formation of estradiol inside cancer cells.
作者简介
Н. Thole
Solvay Pharmaceuticals GmbH
编辑信件的主要联系方式.
Email: info@eco-vector.com
德国, Hanover
G. Chetrite
Institut de Puericulture
Email: info@eco-vector.com
Hormones & Cancer Research Unit
法国, ПарижG. Philippe
Institut de Puericulture
Email: info@eco-vector.com
Hormones & Cancer Research Unit
法国, ПарижJ. Pasqualini
Institut de Puericulture
Email: info@eco-vector.com
Hormones & Cancer Research Unit
法国, Париж